I would agree that REPR pumps should still maintain the cost/performance advantage over competition. Furthermore, somewhere in the neighborhood of 1/3 of their FREEDOM60 sales are for supplies for existing FREEDOM60 users and will not be affected by any new competition as the FREEDOM60 pump only work with tubing sets from REPR because of a patent on the interconnect. Lastly, any change that might occur in Medicare policy only impacts their Medicare customers and does not impact customers with insurance.